Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Citi
Colorcon
Harvard Business School
Express Scripts
Teva

Generated: June 16, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: BUSULFAN

« Back to Dashboard

BUSULFAN

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Actavis Llc BUSULFAN busulfan INJECTABLE;INJECTION 205139 ANDA Actavis Pharma, Inc. 45963-640-57 1 VIAL, SINGLE-DOSE in 1 CARTON (45963-640-57) > 10 mL in 1 VIAL, SINGLE-DOSE
Actavis Llc BUSULFAN busulfan INJECTABLE;INJECTION 205139 ANDA Actavis Pharma, Inc. 45963-640-77 8 VIAL, SINGLE-DOSE in 1 CARTON (45963-640-77) > 10 mL in 1 VIAL, SINGLE-DOSE
Amneal Pharms Co BUSULFAN busulfan INJECTABLE;INJECTION 209580 ANDA Amneal Biosciences LLC 70121-1244-7 8 VIAL, SINGLE-DOSE in 1 CARTON (70121-1244-7) > 10 mL in 1 VIAL, SINGLE-DOSE (70121-1244-1)
Athenex Inc BUSULFAN busulfan INJECTABLE;INJECTION 205106 ANDA Athenex Pharmaceutical Division, LLC. 70860-216-10 8 VIAL in 1 CARTON (70860-216-10) > 10 mL in 1 VIAL (70860-216-41)
Hospira Inc BUSULFAN busulfan INJECTABLE;INJECTION 205672 ANDA Hospira, Inc. 0409-1112-01 8 CARTON in 1 CARTON (0409-1112-01) > 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-1112-10) > 10 mL in 1 VIAL, SINGLE-DOSE
Luitpold BUSULFAN busulfan INJECTABLE;INJECTION 202259 ANDA American Regent, Inc. 0517-0920-08 8 VIAL in 1 PACKAGE (0517-0920-08) > 10 mL in 1 VIAL (0517-0920-01)
Pharmascience Inc BUSULFAN busulfan INJECTABLE;INJECTION 207050 ANDA Sagent Pharmaceuticals 25021-241-10 8 VIAL in 1 CARTON (25021-241-10) > 10 mL in 1 VIAL
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Healthtrust
Johnson and Johnson
QuintilesIMS
Argus Health
Federal Trade Commission